There are currently 53 active clinical trials seeking participants for COVID19 research studies. The states with the highest number of trials for COVID19 participants are Florida, Texas, California and New York.
Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia
NCT04829188
Recruiting
An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.
Gender:
All
Ages:
21 years and above
Trial Updated:
07/26/2023
Locations: UPMC Presbyterian, Pittsburgh, Pennsylvania
Conditions: Sepsis, Pneumonia, Lower Resp Tract Infection, Covid19
Register for Updates
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays
NCT04562285
Recruiting
The primary objective is to assess the ability of COVID-19 IgG and IgM assays to detect an immune response in COVID-19 patients in the Henry Ford Health System (HFHS), both during hospitalization and over the following 12 months.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/18/2023
Locations: Henry Ford Health System, Detroit, Michigan
Conditions: Covid19
Register for Updates
Nebulised Heparin in Patients With Severe COVID-19
NCT04545541
Recruiting
The Can nebulised HepArin Reduce morTality and time to Extubation in Patients with COVID-19 Requiring mechanical ventilation Meta-Trial (CHARTER-MT) is a prospective collaborative individual patient data analysis of randomised controlled trials and early phase studies. Individual studies are being conducted in multiple countries, including Australia, Ireland, the USA, and the UK. Mechanically ventilated patients with confirmed or strongly suspected SARS-CoV-2 infection, hypoxaemia and an acute... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/31/2023
Locations: Frederick Health Hospital, Frederick, Maryland
Conditions: Covid19, Respiratory Failure
Register for Updates
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
NCT05280717
Recruiting
This clinical pharmacology study will evaluate the relative bioavailability, safety, and tolerability of two different concentrations of sotrovimab injections administered at different injection sites in male or female healthy participants aged 18 to 65 years. The study will be conducted in three parts (Part A, an optional Part B and Part C).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/02/2022
Locations: Investigative Site, Riverside, California +9 locations
Conditions: Covid19
Register for Updates
COVID-19 Project ECHO in Nursing Homes
NCT04499391
Recruiting
Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setting. However, little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidenc... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/20/2022
Locations: Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
Conditions: Covid19
Register for Updates
Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
NCT05046561
Recruiting
Protocol STRI12 - Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID-19 (the Study)
Gender:
All
Ages:
18 years and above
Trial Updated:
09/08/2022
Locations: Luna Research, Coral Gables, Florida +12 locations
Conditions: Covid19
Register for Updates
Gazelle COVID-19 Test Clinical Accuracy Protocol
NCT04987918
Recruiting
Gazelle COVID-19 is a fluorescent lateral flow immunoassay and accompanying Reader intended for the qualitative detection of nucleocapsid antigen from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset. The study will be conducted To obtain data to measure the positive percent agreement and negative percent agreement of the Gazelle COVID-19 Test compared to Reverse Transcriptase Polymerase Chain Reaction (... Read More
Gender:
All
Ages:
All
Trial Updated:
08/08/2022
Locations: Northwest Pathology drive thru site, Bellingham International Airport, Bellingham, Washington
Conditions: Covid19
Register for Updates
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults
NCT04798001
Recruiting
This study evaluates an investigational vaccine that is designed to protect humans against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine, MV-014-212, is a live attenuated vaccine against respiratory syncytial virus (RSV) that is expressing the spike (S) protein of SARS-CoV-2. MV-014-212 is administered as drops or a spray in the nose. Specifically, this study analyzes the safety of, and the immune response to, the vaccine when administered... Read More
Gender:
All
Ages:
Between 18 years and 69 years
Trial Updated:
08/01/2022
Locations: Johnson County Clin-Trials, Lenexa, Kansas +1 locations
Conditions: Covid19
Register for Updates
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
NCT04780685
Recruiting
This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID-19 or other potential viral and bacterial pathogens.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/07/2022
Locations: Providence Medical Foundation, Fullerton, California +1 locations
Conditions: Covid19
Register for Updates
Outcomes Mandate National Integration With Cannabis as Medicine
NCT03944447
Recruiting
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Gender:
All
Ages:
7 years and above
Trial Updated:
05/29/2022
Locations: OMNI Medical Services, Boca Raton, Florida +16 locations
Conditions: Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
Register for Updates
COPD Circuit Exercise
NCT05395390
Recruiting
This study is being done to understand body's response to hybrid home-based and on-site rehabilitation program utilizing individually tailored exercises throughout a total of 18 sessions with 12 of them occurring onsite, in people with and without chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA) and in individuals recovered from COVID-19. Exercise training programs vary widely for people with COPD, OSA, and during prolonged reco... Read More
Gender:
All
Ages:
Between 30 years and 85 years
Trial Updated:
05/24/2022
Locations: Texas A&M University, College Station, Texas
Conditions: OSA, Covid19, Residual Symptoms of COVID 19, COPD
Register for Updates
Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19
NCT05045937
Recruiting
Ivermectin is currently being utilized by a number of physicians in the local area. My objective will be to enroll these patients at the time of their evaluation for COVID-19 infection and to follow their progress through their recovery.
Gender:
All
Ages:
Between 12 years and 110 years
Trial Updated:
04/25/2022
Locations: Patrick Robinson MD LLC, San Antonio, Florida
Conditions: Covid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection, COVID-19 Acute Bronchitis
Register for Updates